Reliq Health Technologies Inc. (RHT:TSX.V; RQHTF:OTCQB) announced in a news release it signed contracts with six new Texas-based healthcare groups.
The mobile health and telemedicine solutions company will provide them with its iUGO Care Remote Patient Monitoring and Chronic Care Management modules. For some, it also will provide the iUGO Home product line for specific patient populations. All of these offerings support care coordination and community-based healthcare.
These new clients of Reliq consist of physician practices, home health agencies, a pharmacy network and a home hospice organization, which cumulatively serve more than 3,000 patients with chronic diseases or needing palliative care.
"We are very pleased to welcome six new clients to Reliq’s iUGO Care platform," said Dr. Lisa Crossley, CEO of Reliq Health Technologies. "These six new clients include physician practices, home health agencies, a home hospice organization and a pharmacy network with multiple locations across South Texas. These healthcare organizations will be using the iUGO Care Remote Patient Monitoring (RPM) and Chronic Care Management (CCM) modules, and in some cases the iUGO Home product line for specific patient populations. Together these six care providers serve over 3,000 chronic disease and palliative patients. We expect to go live with all six clients in December."
The company notes that its "powerful iUGO Care platform supports care coordination and community-based healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits."
[NLINSERT]Disclosure:
1) Doresa Banning compiled this article for Streetwise Reports LLC and provides services to Streetwise Reports as an independent contractor. She or members of her household own securities of the following companies mentioned in the article: None. She or members of her household are paid by the following companies mentioned in this article: None.
2) The following companies mentioned in this article are billboard sponsors of Streetwise Reports: None. Click here for important disclosures about sponsor fees. As of the date of this article, an affiliate of Streetwise Reports has a consulting relationship with Reliq Health Technologies. Please click here for more information.
The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.
3) Comments and opinions expressed are those of the specific experts and not of Streetwise Reports or its officers. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.
4) The article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. This article is not a solicitation for investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.
5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the interview or the decision to write an article until three business days after the publication of the interview or article. The foregoing prohibition does not apply to articles that in substance only restate previously published company releases. As of the date of this interview, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of Reliq Health Technologies, a company mentioned in this article.
